Description
Why It’s Done:
• To screen pregnant women for Group B Streptococcus between 35 and 37 weeks of pregnancy, as part of routine prenatal care.
• To assess the risk of GBS transmission from mother to newborn during labor and delivery.
• To guide antibiotic treatment decisions in labor (if the mother tests positive, antibiotics can be given during delivery to prevent transmission to the baby).
• To monitor susceptibility to GBS infections in individuals with weakened immune systems, chronic conditions, or previous GBS infections.
Preparation:
• Sample Collection:
o A blood sample is drawn from a vein in your arm for the test.
• Fasting:
o Fasting is typically not required for this test.
• Medications:
o Inform your healthcare provider about any medications you are taking, as some antibiotics may affect test results.
• Special Instructions:
o If the test is being conducted during pregnancy, follow your healthcare provider’s advice regarding any additional tests or treatments.
